Odronextamab
id:
odronextamab-172-18481802
title:
Odronextamab
text:
Odronextamab, sold under the brand name Ordspono, is a CD20 x CD3 bispecific monoclonal antibody that is used for the treatment of follicular lymphoma or diffuse large B-cell lymphoma. It was developed by Regeneron Pharmaceuticals. The most common side effects include cytokine release syndrome, infections, neutropenia, pyrexia (fever), anemia, thrombocytopenia, and diarrhea. Odronextamab was approved for medical use in the European Union in August 2024.
brand slug:
wiki
category slug:
encyclopedia
description:
Monoclonal antibody
original url:
https://en.wikipedia.org/wiki/Odronextamab
date created:
2023-11-29T04:10:54Z
date modified:
2024-09-02T00:45:34Z
main entity:
{"identifier":"Q123594794","url":"https://www.wikidata.org/entity/Q123594794"}
image:
fields total:
13
integrity:
15